Effect of incorporation of cidofovir into DNA by human cytomegalovirus DNA polymerase on DNA elongation
- PMID: 9055999
- PMCID: PMC163757
- DOI: 10.1128/AAC.41.3.594
Effect of incorporation of cidofovir into DNA by human cytomegalovirus DNA polymerase on DNA elongation
Abstract
Cidofovir (CDV) (HPMPC) has potent in vitro and in vivo activity against human cytomegalovirus (HCMV), CDV diphosphate (CDVpp), the putative antiviral metabolite of CDV, is an inhibitor and an alternate substrate of HCMV DNA polymerase. CDV is incorporated with the correct complementation to dGMP in the template, and the incorporated CDV at the primer end is not excised by the 3'-to-5' exonuclease activity of HCMV DNA polymerase. The incorporation of a CDV molecule causes a decrease in the rate of DNA elongation for the addition of the second natural nucleotide from the singly incorporated CDV molecule. The reduction in the rate of DNA (36-mer) synthesis from an 18-mer by one incorporated CDV is 31% that of the control. However, the fidelity of HCMV DNA polymerase is maintained for the addition of the nucleotides following a single incorporated CDV molecule. The rate of DNA synthesis by HCMV DNA polymerase is drastically decreased after the incorporation of two consecutive CDV molecules; the incorporation of a third consecutive CDV molecule is not detectable. Incorporation of two CDV molecules separated by either one or two deoxynucleoside monophosphates (dAMP, dGMP, or dTMP) also drastically decreases the rate of DNA chain elongation by HCMV DNA polymerase. The rate of DNA synthesis decreases by 90% when a template which contains one internally incorporated CDV molecule is used. The inhibition by CDVpp of DNA synthesis by HCMV DNA polymerase and the inability of HCMV DNA polymerase to excise incorporated CDV from DNA may account for the potent and long-lasting anti-CMV activity of CDV.
Similar articles
-
Kinetic analysis of the interaction of cidofovir diphosphate with human cytomegalovirus DNA polymerase.Biochem Pharmacol. 1996 Jun 14;51(11):1563-7. doi: 10.1016/0006-2952(96)00100-1. Biochem Pharmacol. 1996. PMID: 8630098
-
Cidofovir Diphosphate Inhibits Adenovirus 5 DNA Polymerase via both Nonobligate Chain Termination and Direct Inhibition, and Polymerase Mutations Confer Cidofovir Resistance on Intact Virus.Antimicrob Agents Chemother. 2018 Dec 21;63(1):e01925-18. doi: 10.1128/AAC.01925-18. Print 2019 Jan. Antimicrob Agents Chemother. 2018. PMID: 30397065 Free PMC article.
-
A point mutation in the human cytomegalovirus DNA polymerase gene selected in vitro by cidofovir confers a slow replication phenotype in cell culture.Virology. 1998 Sep 1;248(2):382-93. doi: 10.1006/viro.1998.9299. Virology. 1998. PMID: 9721246
-
A preclinical and clinical overview of the nucleotide-based antiviral agent cidofovir (HPMPC).Adv Exp Med Biol. 1996;394:105-15. doi: 10.1007/978-1-4757-9209-6_12. Adv Exp Med Biol. 1996. PMID: 8815677 Review. No abstract available.
-
[Recent advances in antiviral drugs--antiviral agents to HCMV, HHV-6, and HHV-7].Nihon Rinsho. 1998 Jan;56(1):140-4. Nihon Rinsho. 1998. PMID: 9465679 Review. Japanese.
Cited by
-
Antiviral evaluation of octadecyloxyethyl esters of (S)-3-hydroxy-2-(phosphonomethoxy)propyl nucleosides against herpesviruses and orthopoxviruses.Antiviral Res. 2009 Dec;84(3):254-9. doi: 10.1016/j.antiviral.2009.09.012. Epub 2009 Oct 1. Antiviral Res. 2009. PMID: 19800369 Free PMC article.
-
Engineering of a chimeric RB69 DNA polymerase sensitive to drugs targeting the cytomegalovirus enzyme.J Biol Chem. 2009 Sep 25;284(39):26439-46. doi: 10.1074/jbc.M109.012500. Epub 2009 Jul 21. J Biol Chem. 2009. PMID: 19622750 Free PMC article.
-
Human cytomegalovirus resistance to deoxyribosylindole nucleosides maps to a transversion mutation in the terminase subunit-encoding gene UL89.Antimicrob Agents Chemother. 2015 Jan;59(1):226-32. doi: 10.1128/AAC.03686-14. Epub 2014 Oct 27. Antimicrob Agents Chemother. 2015. PMID: 25348532 Free PMC article.
-
Glycoprotein targeted therapeutics: a new era of anti-herpes simplex virus-1 therapeutics.Rev Med Virol. 2013 May;23(3):194-208. doi: 10.1002/rmv.1740. Epub 2013 Feb 26. Rev Med Virol. 2013. PMID: 23440920 Free PMC article. Review.
-
Antivirals for cytomegalovirus infection in neonates and infants: focus on pharmacokinetics, formulations, dosing, and adverse events.Paediatr Drugs. 2009;11(5):309-21. doi: 10.2165/11316080-000000000-00000. Paediatr Drugs. 2009. PMID: 19725597 Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous